BioNTech
BNTX
BNTX
335 hedge funds and large institutions have $10B invested in BioNTech in 2021 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 93 increasing their positions, 102 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
9% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 102
36% less call options, than puts
Call options by funds: $1.48B | Put options by funds: $2.32B
Holders
335
Holding in Top 10
6
Calls
$1.48B
Puts
$2.32B
Top Buyers
| 1 | +$1.21B | |
| 2 | +$463M | |
| 3 | +$85.3M | |
| 4 |
D.E. Shaw & Co
New York
|
+$84.4M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$75.1M |
Top Sellers
| 1 | -$283M | |
| 2 | -$276M | |
| 3 | -$157M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$130M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$116M |